Page last updated: 2024-11-12
fungiqual
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
fungiqual: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 14422805 |
| MeSH ID | M0169683 |
Synonyms (38)
| Synonym |
|---|
| 12224-02-1 |
| tetrasodium 4,4'-bis((4-(bis(2-hydroxyethyl)amino)-6-((3-sulphonatophenyl)amino)-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonate |
| fungiqual |
| belofor stsd |
| c.i. fluorescent brightenening agent 24 |
| heliofor p |
| whitex bb |
| c.i. fluorescent brightener 24 |
| einecs 235-422-6 |
| tinopal 2b |
| kayaphor bsn |
| tinopal 2bf |
| mikephor bn |
| benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-, tetrasodium salt |
| c.i. fluorescent brightening agent 24 |
| 4,4'-bis(di-(2-hydroxyethyl)amino-4-(3-sulfophenylamino)-1,3,5-triazine-6-ylamino)-stilbene-2,2'-disulfonic acid |
| benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-, sodium salt (1:4) |
| unii-0419jut1k5 |
| 0419jut1k5 , |
| benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt |
| AKOS024428305 |
| fluorescent brightening agent 24 |
| 12768-91-1 |
| fluorescent brightener 87 |
| tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate |
| W-110295 |
| fluorescent brightener 24 |
| 4,4'-bis4-bis(2-hydroxyethyl)amino-6-(3-sulphonatophenyl)amino-1,3,5-triazin-2-ylaminostilbene-2,2'-disulphonate (sodium salt) |
| ci fluorescent brightening agent 24 |
| ci fluorescent brightener 24 |
| 60317-05-7 |
| 4,4'-bis(4-(3-sulfoanilino)-6-(bis(2-hydroxyethyl)amino)-1,3,5-triazin-2-yl)aminostilbene-2,2'-disulfonic acid tetrasodium salt |
| 2,2'-stilbenedisulfonic acid, 4,4'-bis((4-(bis(2-hydroxyethyl)amino)-6-(m-sulfoanilino)-s-triazin-2-yl)amino)-, tetrasodium salt |
| tetrasodium;5-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate |
| Q27247600 |
| 1ST8401 |
| c.i. fluorescent brightener 87 |
| fluorescent brightener 24 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.74) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||